Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer

Quick Facts

• Publication title: Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
• Journal: Elife
• Year: 2023
• DOI: 10.7554/eLife.95305
• PMID/PMCID: 38116754; PMC10732569

Research overview

This peer-reviewed publication presents research in Oncology and Exosome Omics & Biomarkers. Its research topic is reflected in the title: "Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer."

Echo Biotech Role

Echo Biotech contributed EV isolation and purification, EV proteomics.

Related platforms: Exoomics®

Related services and capabilities: Tissue EV Isolation & Purification, EV Proteomics

References

Original publication: Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer Elife. 2023. DOI: 10.7554/eLife.95305. PMID/PMCID: 38116754; PMC10732569.